Summary
CSX Corporation (CSX) filed an 8-K on December 8, 2019, reporting on executive compensation arrangements. Specifically, on December 4, 2019, the company granted stock options to two key officers: Kevin S. Boone, Executive Vice President and Chief Financial Officer, and Nathan D. Goldman, Executive Vice President and Chief Legal Officer. These grants are intended to further align the executives' equity incentives with their responsibilities within the company.
Key Highlights
- 1Stock options granted to CFO Kevin S. Boone (82,169 options) and Chief Legal Officer Nathan D. Goldman (70,431 options).
- 2The stock options have an exercise price of $70.45 per share.
- 3These options are set to vest on December 4, 2022.
- 4The stock options will expire if unexercised by December 3, 2029.
- 5The grants are described as a measure to further align executive equity award incentives with their respective roles.
- 6The event date for these grants was December 3, 2019.
Frequently Asked Questions
CSX granted stock options to Kevin S. Boone (CFO) and Nathan D. Goldman (Chief Legal Officer) to further align their equity award incentives with their roles and responsibilities within the company, aiming to motivate them and tie their compensation to the company's performance.
The stock options have an exercise price of $70.45 per share. They vest on December 4, 2022, meaning the executives can only exercise them after this date. The options will expire if not exercised by December 3, 2029.
No, this 8-K filing does not report any changes in the officers' positions. It specifically addresses the granting of stock options as a compensatory arrangement.
The vesting date of December 4, 2022, indicates that the executives will not be able to realize any financial benefit from these stock options until that date. This structure encourages long-term commitment and performance, as the options become exercisable only after a specified period.